Drug Patents owned by Xeris
1. List of Gvoke Hypopen drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9649364 | XERIS | Methods for producing stable therapeutic formulations in aprotic polar solvents |
Apr, 2036
(13 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Product (NP) | Sep 10, 2022 |
Drugs and Companies using GLUCAGON ingredient
Market Authorisation Date: 10 September, 2019
Treatment: Treatment of severe hypoglycemia
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
GVOKE HYPOPEN family patents
11
United States
2
China
2
South Africa
2
European Union
1
Hong Kong
1
Korea, Republic of
1
Brazil
1
Australia
1
Canada
1
Israel
1
EA
1
Mexico
1
Japan
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic